WHO Classification of Tumours of the Central Nervous System, 4th Edition, 2016
[2]
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System. Acta Neuropathologica. 2016;131(6):803-820
[3]
Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro-Oncology. 2019;21(Suppl 5):v1-v100
[4]
Kaley T, Barani I, Chamberlain M, et al. Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma. Neuro-Oncology. 2014;16(9):1164-1173
[5]
Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. Journal of Neurosurgery. 2015;122(1):4-23
[6]
Goldbrunner R, Minniti G, Preusser M, et al. EANO guidelines for the diagnosis and treatment of meningiomas. The Lancet Oncology. 2016;17(9):e383-e391
[7]
NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers, Version 2.2021